Improving the pharmacokinetics, biodistribution and plasma stability of monobodies
Cancer is a leading cause of death worldwide. Several targeted anticancer drugs entered clinical practice and improved survival of cancer patients with selected tumor types, but therapy resistance and metastatic disease remains a challenge. A major class of targeted anticancer drugs are therapeut...
Saved in:
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Philipps-Universität Marburg
2024
|
Subjects: | |
Online Access: | PDF Full Text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Internet
PDF Full TextCall Number: |
urn:nbn:de:hebis:04-es2024-09070 |
---|---|
Publication Date: |
2024-05-16 |
Source: |
Erstveröffentlichung: Dinh-Fricke AV and Hantschel O (2024), Improving the pharmacokinetics, biodistribution and plasma stability of monobodies. Front. Pharmacol. 15:1393112. https://doi.org/ 10.3389/fphar.2024.1393112 |
Downloads: |
23 (2024) |
License: |
https://creativecommons.org/licenses/by/4.0 |
Access URL: |
https://archiv.ub.uni-marburg.de/es/2024/0907 https://doi.org/10.3389/fphar.2024.1393112 |